Advertisement

Topics

Shanghai ChemPartner Co., Ltd. Company Profile

16:46 EDT 25th September 2017 | BioPortfolio

Founded in 2003, Shanghai ChemPartner Company Ltd. (ChemPartner) is one of the leading contract research organizations providing medicinal chemistry, discovery biology, pharmacology, DMPK, toxicology, process R&D, analytical development, formulation and contract manufacturing services to over 120 pharmaceutical and biotech companies in the world. ChemPartner currently has a team of over 1,000 scientists including over 90 senior scientific leaders with extensive industry experiences gained from leading global pharmaceutical and biotech companies.


News Articles [224 Associated News Articles listed on BioPortfolio]

M&As this week: Shanghai ChemPartner Co, Cell Medica, BBI Group Holding

ShangPharma Corporation's contract research subsidiary Shanghai ChemPartner Co Ltd is set to merge with Quantum Hi-Tech (China) Biological Co Ltd.

Shanghai ChemPartner Plans Reverse Merger with China's Quantum

ShangPharma will merge its Shanghai ChemPartner division, which includes all of the company's CRO/CMO operations, into Quantum Hi-Tech China Biological. The transaction, a reverse merger, allows ChemP...

Shanghai ChemPartner Co., Ltd. Plans Reverse Merger With China's

  Life Sciences Jobs   ...

ShangPharma Announces Second Milestone in Move to Enter Chinese Capital Market

SHANGHAI, June 19, 2017 /PRNewswire/ --  ShangPharma, a leading life science partnering organization providing high-quality and cost-effective drug development and discovery servi...

Dr. Lilly Xu joins ChemPartner as Vice President and Head of DMPK and Exploratory Toxicology

SHANGHAI, July 12, 2017 /PRNewswire/ -- Shanghai ChemPartner today announced the appointment of Lilly Xu, Ph.D. as Vice President and the Head of DMPK and Exploratory Toxicology at the company headqua...

Shanghai Disney Resort Hosts Spectacular One Year Anniversary Celebration With Guests From Across China

Shanghai Disneyland caps incredible first year, welcoming over 11 million guests since its historic June 2016 opening SHANGHAI, June 16, 2017 /PRNewswire/ --Shanghai Disney Resort marked its first...

Shanghai Pharma May Enter $4 Billion Bidding War for Germany's Stada

Shanghai Pharma may bid $4 billion to acquire Stada Arzneimittel, a German generic drugmaker. Stada has already accepted a similar offer from a consortium formed by two private equity firms -- Bain an...

Ennovabio of Shanghai Raises $10 Million to Develop Brain Cancer Drug

Ennovabio, a Shanghai novel drug company, raised $10 million in a pre-A funding, led by HighLight Capital. Ennovabio is developing an innovative drug that targets brain glioma, while it also builds a ...

PubMed Articles [81 Associated PubMed Articles listed on BioPortfolio]

Hexabromocyclododecane and tetrabromobisphenol A in tree bark from different functional areas of Shanghai, China: levels and spatial distributions.

The concentrations and spatial distributions of hexabromocyclododecane (HBCDD) and tetrabromobisphenol A (TBBPA) were measured in tree bark from different functional areas of Shanghai. ΣHBCDD (sum of...

Hospital-Based Case-Control Study of MDS Subtypes and Benzene Exposure in Shanghai.

Due to the sparse data on benzene exposure and myelodysplastic syndrome (MDS) subtypes, we studied this relationship in patients from 29 hospitals in Shanghai, China.

Comparison of air pollution in Shanghai and Lanzhou based on wavelet transform.

For a long-period comparative analysis of air pollution in coastal and inland cities, we analyzed the continuous Morlet wavelet transform on the time series of a 5274-day air pollution index in Shangh...

Incident rate and Risk Factors for Tuberculosis among Patients with Type 2 Diabetes: Retrospective Cohort Study in Shanghai, China.

To examine the incident rate of tuberculosis (TB) and its associates among adults with type 2 diabetes in Shanghai, China.

Impact of Seasons and Festivals on the Onset of Acute Pancreatitis in Shanghai, China.

Seasonal variation on acute pancreatitis (AP) has not been investigated in Eastern Asia. The aims of the study were to assess the association of the onset of AP with the occurrence of seasons and Chin...

Clinical Trials [42 Associated Clinical Trials listed on BioPortfolio]

Shanghai Epidemiology Study for Adolescents and Children With Cancer

The purpose of this study is to describe the morbidity, mortality, disability and survival rate in Shanghai adolescents and children with cancer diagnosed since January 2002.

Progression of Hematopoietic Diseases in Shanghai, China

The purpose of this study is to identify and characterize blood diseases presenting at Shanghai hospitals and to compare them with respect to clinical presentation, phenotype, molecular ch...

Systemic Redesign and Demonstration for Early Detection, Evaluation and Management of Chronic Kidney Disease in Shanghai

Based on clinical evidence based medicine and organizational management model, investigators redesign the prevention and treatment of chronic kidney disease of public health system in Shan...

H7N9 Mix and Match With AS03 and MF59 in Healthy Adults

This Phase II randomized, double-blinded, controlled study in up to 1000 males and non-pregnant females, 19 to 64 years old, inclusive, who are in good health and meet all eligibility crit...

A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women

A prospective cohort study is proposed to evaluate occupational and environmental risk factors for cancer among women in Shanghai, China. Approximately 75,000 women aged 40-69 who reside ...

Companies [111 Associated Companies listed on BioPortfolio]

Shanghai ChemPartner

Founded in 2003, Shanghai ChemPartner (ChemPartner) is one of the leading contract research organizations providing medicinal chemistry, discovery biology, pharmacology, DMPK, toxicology, process ...

Shanghai ChemPartner Co., Ltd.

Founded in 2003, Shanghai ChemPartner Company Ltd. (ChemPartner) is one of the leading contract research organizations providing medicinal chemistry, discovery biology, pharmacology, DMPK, toxicol...

LEAD Therapeutics, Inc.

LEAD Therapeutics began operations in April 2007 as a drug discovery company. LEAD has offices in San Bruno, California, and in Shanghai, China. Drug discovery programs are conduc...

Shanghai Sun Island International Club

Nestled upstream of the Huangpu river that flows to the Shanghai Bund, Shanghai Sun Island is a 160 hectares island resort. Sun Island presents a simple yet sophisticated style that transcends the cos...

Shanghai Medical Technology Co., Ltd.

Shanghai Medical is a leading provider of Hemodialysis and renal care equipment, supplies, and related support services in Eastern China. Specifically, Shanghai Medical distributes and sells Hemod...

More Information about "Shanghai ChemPartner Co., Ltd." on BioPortfolio

We have published hundreds of Shanghai ChemPartner Co., Ltd. news stories on BioPortfolio along with dozens of Shanghai ChemPartner Co., Ltd. Clinical Trials and PubMed Articles about Shanghai ChemPartner Co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Shanghai ChemPartner Co., Ltd. Companies in our database. You can also find out about relevant Shanghai ChemPartner Co., Ltd. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record